Opening on September 1st 2023, the QV Healthcare Practitioner Student Scholarship will award a total of $30,000 in prize money to undergraduate and postgraduate students in Pharmacy, Medicine or Nursing courses in a bid to further the education of the next generation of Australian healthcare practitioners.
Entrants are asked to complete a short essay related to sensitive skin, an area QV understands well having spent decades specialising in skincare for sensitive and problematic skin. Submissions will be judged by a panel of industry experts including Fabrizio Spada (Scientific Affairs Manager, Ego Pharmaceuticals) and Cheryl Talent (President, Eczema Association of Australasia).
QV Skincare, part of the Ego Pharmaceuticals portfolio, has a long and close association with healthcare practitioners since the business was first founded following a request from the dermatology ward of Melbourne’s iconic Queen Victoria Hospital.
Decades on, the QV brand remains family owned, Australian made, and synonymous with quality and innovation. With over 50 QV products sold in more than 20 nations around the world, QV is proud to be the #1 recommended sensitive skincare brand by healthcare practitioners^, a testament to the trust dermatologists, GPs and pharmacists have in the brand.
The QV Healthcare Practitioner Student Scholarship is open from September 1st until September 30th 2023. Interested parties can enter via www.qvskincare.com.au/scholarship.html
For all media enquiries, please contact Ego Pharmaceuticals:
Laura Lock | laura.lock@egopharm.com | +61 438 763 996
QV Healthcare Practitioner Student Scholarship Back For 2023
QV Skincare < 1 mins readMedia
More from this category
- Medical Health Aged Care, Research Development
- 06/09/2024
- 15:19
Breakthrough in the hunt for broad-spectrum malaria therapy
Scientists at La Trobe University have discovered a new antibody-like molecule which could be used in therapy to prevent infection from multiple malaria parasite species. The research, recently published in Nature Communications, found that when the molecule WD34 binds with a protein produced by malaria parasites, it inhibits their ability to infect cells at different stages of the disease. Led by Professor Michael Foley, Professor Robin Anders and PhD candidate Dimuthu Angage at the La Trobe Institute for Molecular Science (LIMS), the research also showed that WD34 can protect against several different malaria parasite species. Professor Foley said the discovery…
- Medical Health Aged Care
- 06/09/2024
- 10:16
NSW Government’s expanded role for pharmacy is reckless and unsafe for patients: RACGP
The New South Wales Government’s move to expand the scope of pharmacists to treat a range of conditions is politically driven and risks the health of people across the state, says the Royal Australian College of GPs. Health Minister Ryan Park made the announcement at a Pharmacy Guild conference last night that work was underway to expand pharmacists' scope to treat ear infections, wound management, nausea, gastro-oesophageal reflux disease, acne, and muscle and joint pain. RACGP NSW Chair Dr Rebekah Hoffman slammed the move as reckless and putting politics before patient safety. “This is politically driven policy, and it has…
- CharitiesAidWelfare, Medical Health Aged Care
- 06/09/2024
- 05:00
Bid for a Cause: Whisky Auction Supports Brain Cancer Fight
After Jack was diagnosed with Glioblastoma Multiforme (GBM), one of the most aggressive and deadly brain cancers, he was given just 12 months to…
- Contains:
Media Outreach made fast, easy, simple.
Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.